Immix Biopharma
IMMX
IMMX
18 hedge funds and large institutions have $1.75M invested in Immix Biopharma in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$539K | |
| 2 | +$137K | |
| 3 | +$61K | |
| 4 |
IW
Imprint Wealth
Mount Pleasant,
South Carolina
|
+$42.3K |
| 5 |
BlackRock
New York
|
+$42.1K |
Top Sellers
| 1 | -$71.7K | |
| 2 | -$52.2K | |
| 3 | -$32.3K | |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$19.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16.8K |